Sign in
CompletedEarly phase 1

To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery.

Key facts

Who runs it
Tan Tock Seng Hospital
Where
Singapore2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Early phase 1
People taking part
50 people enrolled
Started
1 Jan 2022
Ended
1 Sept 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Safety of intracameral levofloxacin in cataract surgery
  • Use of intracameral cefazolin in cataract surgery
Record updated
2 December 2024

Who can take part

Age
50 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Aged ≥50 to <80 years
  • Undergoing cataract surgery under the care of one of three study investigators, all of whom were consultant level cataract surgeons
  • Only those with senile cataracts, assessed using the Lens Opacities Classification System III scale (LOCS III) and without features of complex cataracts were included

Who cannot take part

  • Prior ocular trauma, pregnant, previous history of refractive, corneal or intraocular surgery, cornea endothelial cell count <1500/sqmm², concomitant ocular disease, allergy to penicillin, fluoroquinolone or cephalosporin, and abnormal biometric measurements
  • <50 or >80 years old

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Patients with senile cataracts undergoing phacoemulsification were assigned to receive intracameral levofloxacin (0.1ml/0.5mg) or intracameral cefazolin (0.1ml/1mg). The primary endpoint was the occurrence of endophthalmitis during the 3 month follow-up period. Secondary endpoints included best-corrected visual acuity (BVCA), the presence of anterior chamber (AC) inflammation with grading of AC cells and presence of flare, along with intraocular pressure (IOP), corneal cell thickness (CCT), central foveal thickness (CFT) and cell density.

The 2 groups in the trial

  • Safety of Intracameral levofloxacin in cataract surgeryTreatment being tested

    Eligible and recruited patients are randomized to intracameral levofloxacin or intracameral cefazolin during cataract surgery

    Treatment: Safety of intracameral levofloxacin in cataract surgery and Use of intracameral cefazolin in cataract surgery

  • Use of intracameral cefazolin in cataract surgeryExisting treatment, for comparison

    Eligible and recruited patients were randomized to intracameral levofloxacin or intracameral cefazolin during cataract surgery

    Treatment: Safety of intracameral levofloxacin in cataract surgery and Use of intracameral cefazolin in cataract surgery

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Double-blind, Randomized Controlled Pilot Study Comparing the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Cataract Surgery
Publications
Record updated
2 December 2024